Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05779410
Other study ID # N202010026
Secondary ID A-107-077
Status Completed
Phase N/A
First received
Last updated
Start date January 20, 2021
Est. completion date December 8, 2021

Study information

Verified date February 2023
Source Taipei Medical University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study was to investigate the effects of vitamin D supplementation on biochemical response and aerobic capacity after strenuous endurance exercise (SEE).


Description:

All participants conducted a graded exercise test on an ergometric bicycle to determine the maximal oxygen consumption (VO2max) before and after supplementation, and the speed equivalent to 65% VO2max was conducted for a SEE test by ergometric bicycle for 2 hours, followed by increasing 100 RPM until exhaustion. Venous blood samples were drawn before, immediately after, 2-hour after, 4-hour after, 8-hour after, and 24-hour after the SEE test to determine the concentrations of biomarkers. Data was analyzed by Two-way mixed design ANOVA.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date December 8, 2021
Est. primary completion date December 8, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria: - The volunteers included have conditions as stated below : 1. no history of cardiovascular, liver, kidney and diabetes disease 2. no acute sport injury 3. male adult whose concentration of 25(OH)D is under 30 ng/mL, and maximal oxygen consumption is over 40 ml/kg/min 4. did not participated in any clinical trials or research in the last 3 months before our experiment 5. no supplements were taken during the experimental period 6. were requested to maintain their regular daily life style and avoid alcohol intake Exclusion Criteria: - The volunteers were excluded if they have the situation stated below: 1. history of cardiovascular, liver, kidney and diabetes disease 2. acute sport injury 3. their concentration of 25(OH)D is over 30 ng/mL, or maximal oxygen consumption is under 40 ml/kg/min 4. participated in any clinical trials or experimental research in the last 3 months before our experiment 5. taking supplement during the experimental period 6. did not maintain their regular eating habit or drink alcohol

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Vitamin D
Participants received 5,000 IU of vitamin D orally twice daily for 4 weeks
Medium-chain triglycerides
Participants received the same amount of placebo matching vitamin D orally twice daily for 4 weeks

Locations

Country Name City State
Taiwan Taipei Medical University Taipei

Sponsors (2)

Lead Sponsor Collaborator
Taipei Medical University Panion & BF Biotech Inc.

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Concentration of Neutrophil before exercise
Primary Concentration ofNeutrophil immediately after exercise
Primary Concentration of Neutrophil 2-hour after exercise
Primary Concentration of Neutrophil 4-hour after exercise
Primary Concentration of Neutrophil 8-hour after exercise
Primary Concentration of Neutrophil 24-hour after exercise
Primary Concentration of eosinophil before exercise
Primary Concentration of eosinophil immediately after exercise
Primary Concentration of eosinophil 2-hour after exercise
Primary Concentration of eosinophil 4-hour after exercise
Primary Concentration of eosinophil 8-hour after exercise
Primary Concentration of eosinophil 24-hour after exercise
Primary Concentration of basophil before exercise
Primary Concentration of basophil immediately after exercise
Primary Concentration of basophil 2-hour after exercise
Primary Concentration of basophil 4-hour after exercise
Primary Concentration of basophil 8-hour after exercise
Primary Concentration of basophil 24-hour after exercise
Primary Concentration of monocyte before exercise
Primary Concentration of monocyte immediately after exercise
Primary Concentration of monocyte 2-hour after exercise
Primary Concentration of monocyte 4-hour after exercise
Primary Concentration of monocyte 8-hour after exercise
Primary Concentration of monocyte 24-hour after exercise
Primary Concentration of lymphocyte before exercise
Primary Concentration of lymphocyte immediately after exercise
Primary Concentration of lymphocyte 2-hour after exercise
Primary Concentration of lymphocyte 4-hour after exercise
Primary Concentration of lymphocyte 8-hour after exercise
Primary Concentration of lymphocyte 24-hour after exercise
Primary Concentration of CD4+ before exercise
Primary Concentration of CD4+ immediately after exercise
Primary Concentration of CD4+ 2-hour after exercise
Primary Concentration of CD4+ 4-hour after exercise
Primary Concentration of CD4+ 8-hour after exercise
Primary Concentration of CD4+ 24-hour after exercise
Primary Concentration of CD8+ before exercise
Primary Concentration of CD8+ immediately after exercise
Primary Concentration of CD8+ 2-hour after exercise
Primary Concentration of CD8+ 4-hour after exercise
Primary Concentration of CD8+ 8-hour after exercise
Primary Concentration of CD8+ 24-hour after exercise
Primary Concentration of CD19+ before exercise
Primary Concentration of CD19+ immediately after exercise
Primary Concentration of CD19+ 2-hour after exercise
Primary Concentration of CD19+ 4-hour after exercise
Primary Concentration of CD19+ 8-hour after exercise
Primary Concentration of CD19+ 24-hour after exercise
Primary Concentration of CD56+ before exercise
Primary Concentration of CD56+ immediately after exercise
Primary Concentration of CD56+ 2-hour after exercise
Primary Concentration of CD56+ 4-hour after exercise
Primary Concentration of CD56+ 8-hour after exercise
Primary Concentration of CD56+ 24-hour after exercise
Primary Concentration of IgA before exercise
Primary Concentration of IgA immediately after exercise
Primary Concentration of IgA 2-hour after exercise
Primary Concentration of IgA 4-hour after exercise
Primary Concentration of IgA 8-hour after exercise
Primary Concentration of IgA 24-hour after exercise
Primary Concentration of Cathelicidin before exercise
Primary Concentration of Cathelicidin immediately after exercise
Primary Concentration of Cathelicidin 2-hour after exercise
Primary Concentration of Cathelicidin 4-hour after exercise
Primary Concentration of Cathelicidin 8-hour after exercise
Primary Concentration of Cathelicidin 24-hour after exercise
Primary Concentration of TNF-a before exercise
Primary Concentration of TNF-a immediately after exercise
Primary Concentration of TNF-a 2-hour after exercise
Primary Concentration of TNF-a 4-hour after exercise
Primary Concentration of TNF-a 8-hour after exercise
Primary Concentration of TNF-a 24-hour after exercise
Primary Concentration of IL-1ß before exercise
Primary Concentration of IL-1ß immediately after exercise
Primary Concentration of IL-1ß 2-hour after exercise
Primary Concentration of IL-1ß 4-hour after exercise
Primary Concentration of IL-1ß 8-hour after exercise
Primary Concentration of IL-1ß 24-hour after exercise
Primary Concentration of IFN-? before exercise
Primary Concentration of IFN-? immediately after exercise
Primary Concentration of IFN-? 2-hour after exercise
Primary Concentration of IFN-? 4-hour after exercise
Primary Concentration of IFN-? 8-hour after exercise
Primary Concentration of IFN-? 24-hour after exercise
Primary Concentration of IL-2 before exercise
Primary Concentration of IL-2 immediately after exercise
Primary Concentration of IL-2 2-hour after exercise
Primary Concentration of IL-2 4-hour after exercise
Primary Concentration of IL-2 8-hour after exercise
Primary Concentration of IL-2 24-hour after exercise
Primary Concentration of IL-4 before exercise
Primary Concentration of IL-4 immediately after exercise
Primary Concentration of IL-4 2-hour after exercise
Primary Concentration of IL-4 4-hour after exercise
Primary Concentration of IL-4 8-hour after exercise
Primary Concentration of IL-4 24-hour after exercise
Primary Concentration of IL-8 before exercise
Primary Concentration of IL-8 immediately after exercise
Primary Concentration of IL-8 2-hour after exercise
Primary Concentration of IL-8 4-hour after exercise
Primary Concentration of IL-8 8-hour after exercise
Primary Concentration of IL-8 24-hour after exercise
Primary Concentration of IL-10 before exercise
Primary Concentration of IL-10 immediately after exercise
Primary Concentration of IL-10 2-hour after exercise
Primary Concentration of IL-10 4-hour after exercise
Primary Concentration of IL-10 8-hour after exercise
Primary Concentration of IL-10 24-hour after exercise
Primary Concentration of TBARS before exercise
Primary Concentration of TBARS immediately after exercise
Primary Concentration of TBARS 2-hour after exercise
Primary Concentration of TBARS 4-hour after exercise
Primary Concentration of TBARS 8-hour after exercise
Primary Concentration of TBARS 24-hour after exercise
Primary Concentration of PC before exercise
Primary Concentration of PC immediately after exercise
Primary Concentration of PC 2-hour after exercise
Primary Concentration of PC 4-hour after exercise
Primary Concentration of PC 8-hour after exercise
Primary Concentration of PC 24-hour after exercise
Primary Concentration of SOD before exercise
Primary Concentration of SOD immediately after exercise
Primary Concentration of SOD 2-hour after exercise
Primary Concentration of SOD 4-hour after exercise
Primary Concentration of SOD 8-hour after exercise
Primary Concentration of SOD 24-hour after exercise
Primary Concentration of catalase before exercise
Primary Concentration of catalase immediately after exercise
Primary Concentration of catalase 2-hour after exercise
Primary Concentration of catalase 4-hour after exercise
Primary Concentration of catalase 8-hour after exercise
Primary Concentration of catalase 24-hour after exercise
Primary Concentration of GPx before exercise
Primary Concentration of GPx immediately after exercise
Primary Concentration of GPx 2-hour after exercise
Primary Concentration of GPx 4-hour after exercise
Primary Concentration of GPx 8-hour after exercise
Primary Concentration of GPx 24-hour after exercise
Primary Concentration of CK before exercise
Primary Concentration of CK immediately after exercise
Primary Concentration of CK 2-hour after exercise
Primary Concentration of CK 4-hour after exercise
Primary Concentration of CK 8-hour after exercise
Primary Concentration of CK 24-hour after exercise
Primary Concentration of LDH before exercise
Primary Concentration of LDH immediately after exercise
Primary Concentration of LDH 2-hour after exercise
Primary Concentration of LDH 4-hour after exercise
Primary Concentration of LDH 8-hour after exercise
Primary Concentration of LDH 24-hour after exercise
Primary Concentration of IL-6 before exercise
Primary Concentration of IL-6 immediately after exercise
Primary Concentration of IL-6 2-hour after exercise
Primary Concentration of IL-6 4-hour after exercise
Primary Concentration of IL-6 8-hour after exercise
Primary Concentration of IL-6 24-hour after exercise
Primary Concentration of CRP before exercise
Primary Concentration of CRP immediately after exercise
Primary Concentration of CRP 2-hour after exercise
Primary Concentration of CRP 4-hour after exercise
Primary Concentration of CRP 8-hour after exercise
Primary Concentration of CRP 24-hour after exercise
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1